Who owns IMNM?
Institutional ownership of Immunome Inc. from Form 13F, Q2 2026
202 institutional managers reported holding Immunome Inc. (IMNM) in Form 13F filings for Q2 2026, with 118,037,856 shares worth $2.5B. The largest reported holder was T. Rowe Price Investment Management, Inc. Managers that filed both quarters added a net 2,139,865 shares (+1.8%). 31 opened new positions and 26 sold out.
- Funds holding
- 202
- Value held
- $2.5B
- New / sold out
- 31 / 26
- Net shares, same filers
- +1.8%
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Largest holders of IMNM
Share of 13F holdings is each fund's shares as a share of the 118,037,856 IMNM shares all 13F filers reported, not of shares outstanding.
Biggest buyers in Q2 2026
- T. Rowe Price Investment Management, Inc. Added+$70.2M
- MetLife Investment Management, LLC Added+$17.0M
- BlackRock, Inc. Added+$13.5M
- Wellington Management Group LLP Added+$10.1M
- Goldman Sachs Group Inc Added+$8.7M
- Alerus Financial NA New+$8.1M
- Vanguard Portfolio Management LLC Added+$7.2M
- Dimensional Fund Advisors LP Added+$7.1M
- Readystate Asset Management LP Added+$6.4M
- First Trust Advisors LP New+$5.6M
Biggest sellers in Q2 2026
- Jefferies Financial Group Inc. Sold out-$25.4M
- Price T Rowe Associates Inc Trimmed-$23.0M
- Marshall Wace, LLP Trimmed-$20.8M
- JPMorgan Chase & Co Trimmed-$19.6M
- Polar Capital Holdings Plc Sold out-$18.6M
- Redmile Group, LLC Trimmed-$13.7M
- Woodline Partners LP Trimmed-$12.2M
- Morgan Stanley Trimmed-$9.2M
- Balyasny Asset Management L.P. Sold out-$5.5M
- Primecap Management Co Trimmed-$4.4M
The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $231M and sold $187M; 76 added and 59 trimmed.
Schedule 13D and 13G filings on IMNM
Owners of more than 5% must file within days, so these can be newer than the 13F data.
- 2026-11-16WELLINGTON MANAGEMENT GROUP LLP SCHEDULE 13G filed by Immunome Inc.Schedule 13G
- 2025-08-06FMR LLC SCHEDULE 13G filed by Immunome Inc.Schedule 13G
- 2025-07-29VANGUARD GROUP INC SCHEDULE 13G filed by Immunome Inc.Schedule 13G
Questions about IMNM ownership
- Who owns IMNM stock?
- 202 institutional investment managers reported IMNM positions in their Form 13F filings for Q2 2026, holding 118,037,856 shares worth $2.5B in total. T. Rowe Price Investment Management, Inc. reported the largest position.
- Are funds buying or selling IMNM?
- In Q2 2026, 31 managers opened new IMNM positions, 76 added, 59 trimmed and 26 sold out. Managers that filed in both quarters added a net 2,139,865 shares.
- How current is this IMNM institutional ownership data?
- It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to IMNM by CUSIP. Options are left out. IMNM news and filings · IMNM insider trades · Top funds